Zoetis (ZTS) Accounts Payables (2012 - 2026)
Zoetis' (ZTS) quarterly Accounts Payables came in at $507.0 million in Q1 2026, up 20.71% year-on-year from $420.0 million in Q1 2025, and up 13.93% on a QoQ basis from $445.0 million in Q4 2025.
Zoetis (ZTS) Accounts Payables (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has 15 years of Accounts Payables data on file, last reported at $507.0 million in Q1 2026.
- On a quarterly basis, Accounts Payables rose 20.71% year-over-year to $507.0 million in Q1 2026; TTM through Mar 2026 was $507.0 million, a 20.71% increase from a year earlier, with the FY2025 full-year figure at $445.0 million, up 2.77% from the prior year.
- Accounts Payables for Q1 2026 stood at $507.0 million, up from $445.0 million in the prior quarter.
- Over the last five years, Accounts Payables for ZTS reached as high as $508.0 million in Q2 2025 and fell as low as $373.0 million in Q3 2022.
- Historically, Accounts Payables has averaged $426.4 million across 5 years, with a median of $420.0 million in 2024.
- Across the five-year window, Accounts Payables fell 9.48% in 2024 and rose 20.95% in 2025, its largest moves.
- Year by year, Accounts Payables stood at $405.0 million in 2022, then grew by 1.48% to $411.0 million in 2023, then rose by 5.35% to $433.0 million in 2024, then gained by 2.77% to $445.0 million in 2025, then climbed by 13.93% to $507.0 million in 2026.
- Per Business Quant data, the three most recent Accounts Payables figures were $507.0 million in Q1 2026, $445.0 million in Q4 2025, and $410.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 4.96 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 2.60 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 507.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 3.13 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 498.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 1.67 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.75 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 773.00 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 372.00 Mn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 58.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 507.00 Mn |
| Dec 31, 2025 | 445.00 Mn |
| Sep 30, 2025 | 410.00 Mn |
| Jun 30, 2025 | 508.00 Mn |
| Mar 31, 2025 | 420.00 Mn |
| Dec 31, 2024 | 433.00 Mn |
| Sep 30, 2024 | 404.00 Mn |
| Jun 30, 2024 | 420.00 Mn |
| Mar 31, 2024 | 405.00 Mn |
| Dec 31, 2023 | 411.00 Mn |
| Sep 30, 2023 | 388.00 Mn |
| Jun 30, 2023 | 464.00 Mn |
| Mar 31, 2023 | 424.00 Mn |
| Dec 31, 2022 | 405.00 Mn |
| Sep 30, 2022 | 373.00 Mn |
| Jun 30, 2022 | 430.00 Mn |
| Mar 31, 2022 | 402.00 Mn |
| Dec 31, 2021 | 436.00 Mn |
| Sep 30, 2021 | 387.00 Mn |
| Jun 30, 2021 | 369.00 Mn |